Over the projected period, the antibody treatment market share is anticipated to rise at a consistent 13.4% CAGR. By 2033, the market is projected to have grown from its 2023 projection of US$ 235 billion to a valuation of US$ 824.0 billion. Since they offer tailored and targeted approaches to the treatment of a wide range of ailments, including cancer and autoimmune disorders,...